To: David B. Higgs who wrote (5817 ) 5/10/1998 11:58:00 PM From: DJBEINO Respond to of 8193
Cirrus Electronic Buyers News by Jennifer L. Baljko Having survived a major restructuring last year, Cirrus Logic Inc. is now warding off reports that it may be taken over by its largest investor. Several news reports last week indicated that Alfred Teo, who holds a 9.4% stake in the Fremont, Calif., chip maker, with about 6.4 million shares, may buy the company and take it private. But even if Teo intends to beef up his position, a poison-pill defense mechanism adopted last week will make it difficult-and more expensive-for such an attempt to occur, observers said. While Teo could not be reached for comment, the private investor and executive at several plastics companies is a "long-term-value shareholder" who buys undervalued stocks to boost his portfolio, said Bonnie McBride, Cirrus' director of investor relations. Teo had not previously voiced any plans to acquire Cirrus, McBride added. Although McBride said a meeting with Teo has been scheduled, she stressed that the poison pill does not reflect any action on his part to take control of Cirrus. "The poison pill is something companies of Cirrus' size often put in place," she said. Under the poison-pill mechanism, investors may buy $120 worth of common stock for $60 if anyone obtains more than a 15% stake in the company. By discounting the price, an investor will have a harder time pursuing a hostile takeover, explained analyst Charles Boucher of Donaldson Lufkin & Jenrette Securities, San Francisco. "If he makes a tender offer to other shareholders, this would make life unpleasant for him," Boucher said. Teo's wife, Annie Teo, who jointly owns a majority of the shares, said a takeover seems unlikely. "My husband has never taken over a company, and he's been in a position where he could have done that before," she said. Cirrus recently underwent a major reorganization involving layoffs, product consolidation, and a re-emphasis on core competencies. After two years of losses, the company posted net income of $36.5 million on sales of $954.3 million in fiscal 1998. The reports sparked activity on Wall Street last week, pushing Cirrus' stock price 10% higher. For the past several months, Cirrus stock has been trading at roughly $10, a 40% drop from a 52-week high of $17.75 in September.